Market Analysis and Insights: Global Organs-on-chips (OOC) Market
An organ-on-chip (OOC) is also called a multi-channel 3-D microfluidic cell culture chip. It is a type of artificial organ that stimulates the activity, mechanics, and physiological response of entire organs and organ systems. The size of an OOC is about that of an AA battery and its transparency allows to see the organ’s functionality, behavior, and response, at the cellular and molecular levels.
The global Organs-on-chips (OOC) market size is projected to reach US$ 455.5 million by 2028, from US$ 42 million in 2021, at a CAGR of 39.9% during 2022-2028.
North America dominated the organs-on-chips market in 2017, due to factors such as support from government bodies and advantages of OOCs.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Organs-on-chips (OOC) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Organs-on-chips (OOC) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Organs-on-chips (OOC) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Organs-on-chips (OOC) market.
Global Organs-on-chips (OOC) Scope and Market Size
Organs-on-chips (OOC) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Organs-on-chips (OOC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Heart
Liver
Lung
Other Organs
Segment by Application
Drug Discovery
Toxicology Research
Other Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AxoSim
BioIVT
Emulate
Elveflow
MIMETAS
Nortis
Hurel Corporation
InSphero
Tara Biosystems
TissUse